Similarly, in rheumatoid arthritis patients, accumulation of pro-inflammatory M1 macrophages contribute to an imbalanced M1/M2 ratio during the disease flare, however in the remission phase, CD206+ M2 macrophages positively contribute to the disease resolution via releasing anti-inflammatory cytokines (30). This evidence concerns the gene MRC1 and rheumatoid arthritis.